Top Markets
Coin of the day
Renalytix Plc Renalytix Plc

Renalytix Plc

RNLX
Classifica tra le azioni #33998
Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc... Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease. The company's technology is applied in various areas: identifying and predicting the course of kidney disease, informing clinical treatment, selecting patients for pharmaceutical trials, and discovering new therapeutic targets. Renalytix has formed several strategic collaborations, such as licensing agreements with Mount Sinai Health System for AI-assisted kidney disease diagnosis, with Joslin Diabetes Center, Inc. for developing biomarker-based kidney disease prediction products, and with Kantaro Biosciences LLC for laboratory tests to detect SARS-CoV-2 antibodies. Furthermore, it has partnered with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to introduce an innovative clinical care model aimed at improving kidney health outcomes and preventing disease advancement and failure in vulnerable populations.
Prezzo delle azioni
$0.1502
Ultima sincronizzazione: 2024-11-04
Capitalizzazione di mercato
$6.43M
Variazione (1 giorno)
-5.45%
Variazione (1 anno)
0.00%
Paese
US
Scambia Renalytix Plc (RNLX)

Categoria

EPS per Renalytix Plc (RNLX)
EPS al September 2024 TTM: $-0.52
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Renalytix Plc, l’EPS attuale della società (TTM) è $-0.52. Alla fine del 2023, la società aveva un EPS di $-1.10 una diminuzione rispetto a rispetto a quello del 2022, che era di $-1.24.
Storico EPS per Renalytix Plc da 2018 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $-0.52 -16.13%
2024 $-0.62 -43.64%
2023 $-1.10 -11.29%
2022 $-1.24 26.53%
2021 $-0.98 188.24%
2020 $-0.34 -82.83%
2019 $-1.98 3,200.00%
2018 $-0.06 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
$3.48 -769.23%
US
$1.50 -388.62%
AU
$1.43 -375.00%
US
$-1.43 175.00%
US
- -
US